Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

USFDA completes audit at Dr. Reddy’s Laboratories’ Vizag Plants

Date: 24-06-2019

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ Formulations Manufacturing Plants (Vizag SEZ Plant 1 and Vizag SEZ Plant 2) at Duvvada in Visakhapatnam. The audit was completed on June 21, 2019. The company has been issued a Form 483 with 2 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.